CAI Insider Trading Activity and SEC Form 4 Filings
CAI insider trading summary
Over the past 12 months, insiders at Caris Life Sciences, Inc. (CAI) reported 7 sales worth $28.9M by 4 insiders and 3 open-market purchases worth $612K by 3 insiders on SEC Form 4. Net insider selling was $28.2M.
Latest CAI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 22, 2026 | John Russel Denton | See Remarks | Sell | $239K (7,500 @ $31.82) |
| Sep 17, 2026 | Brian J Brille | See Remarks | Sell | $12.1M (400,000 @ $30.33) |
| Sep 4, 2026 | David Baxley Spetzler | President | Sell | $3.0M (119,212 @ $24.76) |
| Sep 3, 2026 | David Baxley Spetzler | President | Sell | $9.7M (393,100 @ $24.76) |
| Sep 3, 2026 | David Baxley Spetzler | President | Sell | $2.1M (84,900 @ $25.32) |
| May 11, 2026 | Jeff L Vacirca | Director | Buy | $501K (31,050 @ $16.15) |
| Dec 11, 2025 | Luke Thomas Power | See Remarks | Sell | $38K (1,400 @ $27.16) |
| Dec 11, 2025 | Luke Thomas Power | See Remarks | Sell | $1.6M (60,850 @ $26.56) |
| Nov 7, 2025 | John Russel Denton | See Remarks | Buy | $101K (4,184 @ $24.09) |
| Nov 7, 2025 | David Baxley Spetzler | President | Buy | $10K (400 @ $23.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.